chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Paraesthesia, Peripheral sensory neuropathy, Physical examination normal
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Areflexia, Asthenia, Babinski reflex test, Culture, Electromyogram abnormal
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Gait disturbance, Grip strength decreased, Hypoaesthesia, Hypotonia, Immunology test
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Immunology test normal, Joint range of motion decreased, Lumbar puncture normal, Muscular weakness, Neurological examination normal
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Neuropathy peripheral, Pain in extremity, Paraesthesia, Polymerase chain reaction, Pulmonary function test
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Viral test negative
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Asthenia, Blood product transfusion, CSF cell count normal, CSF protein increased, Electromyogram abnormal
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Fatigue, Guillain-Barre syndrome, Impaired work ability, Neuropathy peripheral, Pain in extremity
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Quadriparesis
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Abasia, Areflexia, Asthenia, Axonal neuropathy, Babinski reflex test
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Blood product transfusion, CSF culture, Electromyogram abnormal, Gait disturbance, Grip strength decreased
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Immunology test, Intensive care, Lumbar puncture
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Lumbar puncture normal, Muscular weakness, Pain in extremity, Paraesthesia, Peripheral sensorimotor neuropathy
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 18.0
Sex: M
Vaccine: FLUN3, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF, FLUN3, HEPAB, IPV, TDAP, YF
Symptoms: Polymerase chain reaction, Pulmonary function test, Reflexes abnormal, Serology normal
Clinical narrative: FOLLOW UP VAERS (Original VAERS (Original VAERS #262657 filed on 9/6/2006. Updated information attached.  Discharged from the military and lost to follow up.  19 year-old male, retired due to Guillan-Barre syndrome. He presents today for periodic re-evaluation in accordance with orders. He was well until on/about 31 Aug 2006 when he initially-developed "achy" pain in his arms. Over the next 3 days, he developed rapidly progressive quadriparesis. At nadir, he could not lift his arms over his shoulders and could not walk without assistance. He presented to "medical center" for evaluation and was diagnosed with Guillain-Barre syndrome. EMG/NCS was consistent with a severe motor-greater-than-sensory mulitfocal peripheral neuropathy, felt-consistent. Early lumbar puncture had normal cell count, with a protein relatively elevated-for-age. He was treated with intravenous immunoglobulin. Subsequently, he had partial improvement in quadriparesis, but continued with moderate-severe distal weakness, so he was medically retired. He reports being at nadir for about 1-2 weeks, then had majority of improvement by Dec 2006. Since Dec 2006 he has continued at his current state. He reports generally feeling well. Seems not to have significant motor weakness. However, he reports a baseline fatigue/tiredness and general decease in energy level which remains functionally-limiting. As a result, he feels he cannot maintain a full-time job.
Age: 20.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Rash generalised
Clinical narrative: Rash 9 days post AVA #2.  No prior hx, over entire body.  Skin was red.
Age: 20.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Erythema, Rash generalised
Clinical narrative: Rash 9 days post AVA #2.  No prior hx, over entire body.  Skin was red.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4
Symptoms: Alcohol abuse, Carbon dioxide decreased, Confusional state, Convulsion, Dehydration
Clinical narrative: Information has been received from a consumer concerning her daughter an 18 year old female with no known drug allergies/reactions and no pertinent medical history reported who on 16-JUN-2008 was vaccinated with the first dose of GARDASIL. On 19-AUG-2008, the patient was vaccinated with a second dose of GARDASIL. Concomitant therapy included MENACTRA. On 16-JUN-2008, and after receiving the first dose of GARDASIL, the patient had severe pain at the injection site. Then, on 21-JUN-2008, she was taken by ambulance to the emergency room because she had fainting spells. While in the emergency room she had an electrocardiogram (EKG) done and the emergency room physician diagnosed with vasovagal, and she was able to gone that day. The consumer reported that the patient then received the second dose of GARDASIL, and she also had severe pain at the injection site again. Then, on 02-SEP-2008, she had two seizures. The consumer reported that the patient was then sent to the hospital at 10:30 PM on 02-SEP-2008 by ambulance because of the seizures and was then admitted to the hospital at 12:00 AM. At the time the patient was admitted she had a computed axial tomography (CAT scan), a magnetic resonance imaging (MRI) and a electroencephalography (EEG) done. The patient was the diagnosed with early onset seizure disorder and was prescribed KEPPRA (manufacturer unspecified)) and she can not drive for 6 months. The consumer reported the patient was then able to leave the hospital on 03-SEP-2008 at 8:30 PM. The consumer stated that the patient has not had a seizure since but it may because of the medication she is taking. The patient will not receive the third dose of GARDASIL. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4
Symptoms: Epilepsy, Full blood count normal, Grand mal convulsion, Headache, Hyperkinesia
Clinical narrative: Information has been received from a consumer concerning her daughter an 18 year old female with no known drug allergies/reactions and no pertinent medical history reported who on 16-JUN-2008 was vaccinated with the first dose of GARDASIL. On 19-AUG-2008, the patient was vaccinated with a second dose of GARDASIL. Concomitant therapy included MENACTRA. On 16-JUN-2008, and after receiving the first dose of GARDASIL, the patient had severe pain at the injection site. Then, on 21-JUN-2008, she was taken by ambulance to the emergency room because she had fainting spells. While in the emergency room she had an electrocardiogram (EKG) done and the emergency room physician diagnosed with vasovagal, and she was able to gone that day. The consumer reported that the patient then received the second dose of GARDASIL, and she also had severe pain at the injection site again. Then, on 02-SEP-2008, she had two seizures. The consumer reported that the patient was then sent to the hospital at 10:30 PM on 02-SEP-2008 by ambulance because of the seizures and was then admitted to the hospital at 12:00 AM. At the time the patient was admitted she had a computed axial tomography (CAT scan), a magnetic resonance imaging (MRI) and a electroencephalography (EEG) done. The patient was the diagnosed with early onset seizure disorder and was prescribed KEPPRA (manufacturer unspecified)) and she can not drive for 6 months. The consumer reported the patient was then able to leave the hospital on 03-SEP-2008 at 8:30 PM. The consumer stated that the patient has not had a seizure since but it may because of the medication she is taking. The patient will not receive the third dose of GARDASIL. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4
Symptoms: Laboratory test normal, Loss of consciousness, Memory impairment, Presyncope, Syncope
Clinical narrative: Information has been received from a consumer concerning her daughter an 18 year old female with no known drug allergies/reactions and no pertinent medical history reported who on 16-JUN-2008 was vaccinated with the first dose of GARDASIL. On 19-AUG-2008, the patient was vaccinated with a second dose of GARDASIL. Concomitant therapy included MENACTRA. On 16-JUN-2008, and after receiving the first dose of GARDASIL, the patient had severe pain at the injection site. Then, on 21-JUN-2008, she was taken by ambulance to the emergency room because she had fainting spells. While in the emergency room she had an electrocardiogram (EKG) done and the emergency room physician diagnosed with vasovagal, and she was able to gone that day. The consumer reported that the patient then received the second dose of GARDASIL, and she also had severe pain at the injection site again. Then, on 02-SEP-2008, she had two seizures. The consumer reported that the patient was then sent to the hospital at 10:30 PM on 02-SEP-2008 by ambulance because of the seizures and was then admitted to the hospital at 12:00 AM. At the time the patient was admitted she had a computed axial tomography (CAT scan), a magnetic resonance imaging (MRI) and a electroencephalography (EEG) done. The patient was the diagnosed with early onset seizure disorder and was prescribed KEPPRA (manufacturer unspecified)) and she can not drive for 6 months. The consumer reported the patient was then able to leave the hospital on 03-SEP-2008 at 8:30 PM. The consumer stated that the patient has not had a seizure since but it may because of the medication she is taking. The patient will not receive the third dose of GARDASIL. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4
Symptoms: Urine analysis normal
Clinical narrative: Information has been received from a consumer concerning her daughter an 18 year old female with no known drug allergies/reactions and no pertinent medical history reported who on 16-JUN-2008 was vaccinated with the first dose of GARDASIL. On 19-AUG-2008, the patient was vaccinated with a second dose of GARDASIL. Concomitant therapy included MENACTRA. On 16-JUN-2008, and after receiving the first dose of GARDASIL, the patient had severe pain at the injection site. Then, on 21-JUN-2008, she was taken by ambulance to the emergency room because she had fainting spells. While in the emergency room she had an electrocardiogram (EKG) done and the emergency room physician diagnosed with vasovagal, and she was able to gone that day. The consumer reported that the patient then received the second dose of GARDASIL, and she also had severe pain at the injection site again. Then, on 02-SEP-2008, she had two seizures. The consumer reported that the patient was then sent to the hospital at 10:30 PM on 02-SEP-2008 by ambulance because of the seizures and was then admitted to the hospital at 12:00 AM. At the time the patient was admitted she had a computed axial tomography (CAT scan), a magnetic resonance imaging (MRI) and a electroencephalography (EEG) done. The patient was the diagnosed with early onset seizure disorder and was prescribed KEPPRA (manufacturer unspecified)) and she can not drive for 6 months. The consumer reported the patient was then able to leave the hospital on 03-SEP-2008 at 8:30 PM. The consumer stated that the patient has not had a seizure since but it may because of the medication she is taking. The patient will not receive the third dose of GARDASIL. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4
Symptoms: Computerised tomogram abnormal, Convulsion, Electrocardiogram abnormal, Electroencephalogram abnormal, Injection site pain
Clinical narrative: Information has been received from a consumer concerning her daughter an 18 year old female with no known drug allergies/reactions and no pertinent medical history reported who on 16-JUN-2008 was vaccinated with the first dose of GARDASIL. On 19-AUG-2008, the patient was vaccinated with a second dose of GARDASIL. Concomitant therapy included MENACTRA. On 16-JUN-2008, and after receiving the first dose of GARDASIL, the patient had severe pain at the injection site. Then, on 21-JUN-2008, she was taken by ambulance to the emergency room because she had fainting spells. While in the emergency room she had an electrocardiogram (EKG) done and the emergency room physician diagnosed with vasovagal, and she was able to gone that day. The consumer reported that the patient then received the second dose of GARDASIL, and she also had severe pain at the injection site again. Then, on 02-SEP-2008, she had two seizures. The consumer reported that the patient was then sent to the hospital at 10:30 PM on 02-SEP-2008 by ambulance because of the seizures and was then admitted to the hospital at 12:00 AM. At the time the patient was admitted she had a computed axial tomography (CAT scan), a magnetic resonance imaging (MRI) and a electroencephalography (EEG) done. The patient was the diagnosed with early onset seizure disorder and was prescribed KEPPRA (manufacturer unspecified)) and she can not drive for 6 months. The consumer reported the patient was then able to leave the hospital on 03-SEP-2008 at 8:30 PM. The consumer stated that the patient has not had a seizure since but it may because of the medication she is taking. The patient will not receive the third dose of GARDASIL. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, HPV4
Symptoms: Nuclear magnetic resonance imaging abnormal, Syncope, Syncope vasovagal, Vaccine positive rechallenge
Clinical narrative: Information has been received from a consumer concerning her daughter an 18 year old female with no known drug allergies/reactions and no pertinent medical history reported who on 16-JUN-2008 was vaccinated with the first dose of GARDASIL. On 19-AUG-2008, the patient was vaccinated with a second dose of GARDASIL. Concomitant therapy included MENACTRA. On 16-JUN-2008, and after receiving the first dose of GARDASIL, the patient had severe pain at the injection site. Then, on 21-JUN-2008, she was taken by ambulance to the emergency room because she had fainting spells. While in the emergency room she had an electrocardiogram (EKG) done and the emergency room physician diagnosed with vasovagal, and she was able to gone that day. The consumer reported that the patient then received the second dose of GARDASIL, and she also had severe pain at the injection site again. Then, on 02-SEP-2008, she had two seizures. The consumer reported that the patient was then sent to the hospital at 10:30 PM on 02-SEP-2008 by ambulance because of the seizures and was then admitted to the hospital at 12:00 AM. At the time the patient was admitted she had a computed axial tomography (CAT scan), a magnetic resonance imaging (MRI) and a electroencephalography (EEG) done. The patient was the diagnosed with early onset seizure disorder and was prescribed KEPPRA (manufacturer unspecified)) and she can not drive for 6 months. The consumer reported the patient was then able to leave the hospital on 03-SEP-2008 at 8:30 PM. The consumer stated that the patient has not had a seizure since but it may because of the medication she is taking. The patient will not receive the third dose of GARDASIL. Additional information has been requested.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Multiple sclerosis
Clinical narrative: Two years after receiving Anthrax vaccine was diagnosed with multiple sclerosis. 12/16/08-records received for DOS 9/25/07-PMH: developed hypothyroidism in January 2004, in 2005-2006 marked weight gain, fatigue and weakness. Hypogonadism and pseudo Cushings's syndrome (hypercortisolism). Presently stable, with some generalized fatigue, lack of energy and intermittent paresthesias in left side of face, trunk and back and noted left foot inversion.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Induration, Pruritus, Skin warm
Clinical narrative: Patient developed a large 7 x8 cm itchy area of induration, erythema, and warm with small shallow blisters in the center of the lesion, which were filled with yellow exudate.  Treated with hydroxyzine and hydrocortisone.  No systemic signs of illness.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Erythema, Injection site pruritus, Rash macular
Clinical narrative: red splotches and itching at injection site
Age: 1.08
Sex: M
Vaccine: MMRV
Symptoms: Pyrexia, Vaccination complication, Varicella post vaccine
Clinical narrative: WIthin 24 hrs of vaccinations being administered my son, who has never been ill, spiked a fever of 103.  He had a trip to the Er, a house call and a follow up visit with his primary physican during the next 3 days.  His fever did not subside for four days.  Four weeks later he developed a case of chicken pox, one of the shots he had been given.  The dr was surprised at the severity of his case as well as the timing.  He firmly believes the fever following his vacinations is directly related to his immunizations.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Arthralgia, Rash
Clinical narrative: Information has been received from a medical assistant a concerning a 15 year old female who on 14-JAN-2008, was vaccinated with the first dose of GARDASIL, on 12-MAR-2008 with the second of GARDASIL and on 14-JUL-2008 with the third dose of GARDASIL. In July 2008, the patient had rash and bumps on her legs and chest and left side of body. The patient's rash then went away but she developed achy joints. These adverse events occurred after the third dose of GARDASIL in July 2008. No adverse reactions were reported after the first or second dose of GARDASIL was given. At time of reporting, the patient was not yet recovered from achy joints. No other information available from medical assistant. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: HPV4
Symptoms: Condition aggravated, Convulsion
Clinical narrative: Information has been received from a physician concerning a female with a history of seizures who on an unspecified date was vaccinated with the second dose of GARDASIL. Subsequently, "a couple months later", the patient experienced a seizure. On an unspecified date, the patient recovered from seizure. The patient sought unspecified medical attention. Seizure was considered to be immediately life-threatening. Additional information has been requested.  5/29/09 Neurology DOS 7/10/08 to 9/25/08. Includes copy of ER medical records of 6/19/08 previously abstracted. FINAL DIAGNOSIS: Complex Partial Seizures Post vaccination awoke with nosebleed. Later found thrashing in bed having seizure, head back and to the left, eyes rolled back, left arm banging bacl and forth and drooling. Seen at local hospital ER then transferred to higher level of care. Another event occured consisting of staring and drooling at that facility. Upon discharge had two more events and returned again to the ER. The evening of 7/9/08 at home and on 7/10/08 during EEG she had an events consisting of chewing, mouthing movements, staring, and difficulty speaking.   5/29/09 Received ER medical records of 6/19/08. FINAL DX: new onset seizure Records reveal patient experienced bloody nose, left sided shaking spell, eyes rolled back, drooling, dazed appearance followed by postictal state.  Had been seen in outlying hospital & transferred to higher level of care.  Phone consult w/peds neuro suggested benign focal epilepsy.  Recommended meds which family declined.  D/C to home w/outpatient neuro consult.  Neuro addendum states parent reported additional staring/drooling on way home, again offered meds & again parents declined.   6/8/09 Received ER medical records of 6/19/2008. FINAL DX: seizure Records reveal patient experienced nosebleed, went to bed. Awakened parents later w/noise & found to be shaking, drooling for approx 1 min.  Then confused, garbled speech w/no memory of event.  Transferred to higher level of care.  6/8/09 Received ER medical records of 2/6/09. FINAL DX: exudative pharyngitis; dehydration Records reveal ptient experienced fever & sore throat x 2 days & vomiting x 1 day.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Premature rupture of membranes, Suppressed lactation, Ultrasound scan
Clinical narrative: Initial and follow up information has been received for the Pregnancy Registry for GARDASIL from an office medical assistant and nurse practitioner concerning a 23 year old female with a history of migraine headaches and HPV and no previous pregnancies who on 11-JUN-2007 was vaccinated with her first dose of GARDASIL (lot #657868/0523U). On 07-AUG-2007 the patient received her second dose of GARDASIL (lot# 658554/0928U). On 20-DEC-2007 the patient came in the office for her third dose of GARDASIL (lot# 659441/1446U). The patient did receive the third dose that day, but during conversation she mentioned she had been spotting and had stopped taking her birth control. The office medical assistant reported that later on that day, they had found out that the patient was pregnant. The patient's last menstrual period was 01-NOV-2007 (previously reported as 03-DEC-2007) and estimated date of delivery by ultrasound was 20-AUG-2008. An ultrasound was performed that showed 5 weeks gestation. No adverse event was involved that time. Medical attention was sought, by a physician. Follow-up information was received. On 14-JUL-2008 the patient experienced premature rupture of membranes and delivered a normal, healthy male baby weighing 5 pounds 10 ounces at 34 weeks. There were no congenital anomalies. The infant with apgar scores of 6.8 was in NICU for breathing. Meconium stained membranes were noted on placenta pathology. Concomitant therapy included UNISOM for insomnia and ZANTAC for heartburn. The patient also noticed decreased milk production during breast feeding. Upon internal review, in NICU for breathing was determined to be an other important medical event. Follow-up information was received from a physician who reported that the mother was not a patient of his and the baby's name was a name unknown to him. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: TTOX, VARCEL
Symptoms: Chest X-ray abnormal, Mechanical ventilation, Pneumonia, Skin lesion, Stomatitis
Clinical narrative: Information has been received from a nurse concerning a 12-13 year old female with allergy to DTaP (manufacturer unknown) and cerebral palsy who on approximately 01-SEP-2008 was vaccinated with VARIVAX (Oka/Merck). Concomitant therapy included tetanus toxoid. That same day, patient went to the doctor with a cold and cough. The patient came back 3 days later on approximately 04-SEP-2008 for a chest x-ray, at which point physician indicated that the patient had pneumonia. The patient was then hospitalized and was still there. While she was in the hospital, developed sores in the mouth and body and she had chickenpox. She was put on a ventilator. The patient was recovering from pneumonia, sores in the mouth and body, and chickenpox. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: TTOX, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse concerning a 12-13 year old female with allergy to DTaP (manufacturer unknown) and cerebral palsy who on approximately 01-SEP-2008 was vaccinated with VARIVAX (Oka/Merck). Concomitant therapy included tetanus toxoid. That same day, patient went to the doctor with a cold and cough. The patient came back 3 days later on approximately 04-SEP-2008 for a chest x-ray, at which point physician indicated that the patient had pneumonia. The patient was then hospitalized and was still there. While she was in the hospital, developed sores in the mouth and body and she had chickenpox. She was put on a ventilator. The patient was recovering from pneumonia, sores in the mouth and body, and chickenpox. Additional information has been requested.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Back pain, Bursitis, Gait disturbance, Intervertebral disc degeneration
Clinical narrative: Information has been received from a nurse practitioner concerning a 74 year old female with morphine and penicillin allergies, diabetes, hypertension and hyperlipidaemia who on 23-APR-2008 was vaccinated with ZOSTAVAX (Oka/Merck) (lot # 656858/0356U). Concomitant therapy included ACTOS, NORVASC, glyburide, metoprolol, metformin, simvastatin (MSD) and lisinopril-HCTZ. On 24-APR-2008, approximately 24 hours after vaccination the patient was "flat on her back with muscle aches and back aches. It was like night and day." She went to her physician on 29-APR-2008 and was found to have left sciatica down to her left anterior thigh. She had a "positive straight leg raise". She was treated with MEDROL, cyclobenzaprine hydrochloride (MSD) and TYLENOL with codeine. She also had xrays done. The patient then saw an orthopedist in May 2008 for an evaluation. An MRI of her lumbar spine indicated degenerative disc disease with disc protrusion in L3 and L4. She had diminished range of motion and tenderness of the left hip. Her reflexes are "okay" and there is no spinal stenosis. The orthopedist concluded degenerative disc disease with left bursitis. The patient was injected with a steroid and had xrays done. At some point she had to be in a wheel chair but currently she is using a walker. Left bursitis and degenerative disc were considered to be disabling. No other details. Additional information has been requested.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Intervertebral disc protrusion, Joint range of motion decreased, Myalgia, Nuclear magnetic resonance imaging abnormal, Reflex test normal
Clinical narrative: Information has been received from a nurse practitioner concerning a 74 year old female with morphine and penicillin allergies, diabetes, hypertension and hyperlipidaemia who on 23-APR-2008 was vaccinated with ZOSTAVAX (Oka/Merck) (lot # 656858/0356U). Concomitant therapy included ACTOS, NORVASC, glyburide, metoprolol, metformin, simvastatin (MSD) and lisinopril-HCTZ. On 24-APR-2008, approximately 24 hours after vaccination the patient was "flat on her back with muscle aches and back aches. It was like night and day." She went to her physician on 29-APR-2008 and was found to have left sciatica down to her left anterior thigh. She had a "positive straight leg raise". She was treated with MEDROL, cyclobenzaprine hydrochloride (MSD) and TYLENOL with codeine. She also had xrays done. The patient then saw an orthopedist in May 2008 for an evaluation. An MRI of her lumbar spine indicated degenerative disc disease with disc protrusion in L3 and L4. She had diminished range of motion and tenderness of the left hip. Her reflexes are "okay" and there is no spinal stenosis. The orthopedist concluded degenerative disc disease with left bursitis. The patient was injected with a steroid and had xrays done. At some point she had to be in a wheel chair but currently she is using a walker. Left bursitis and degenerative disc were considered to be disabling. No other details. Additional information has been requested.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Sciatica, Tenderness, X-ray
Clinical narrative: Information has been received from a nurse practitioner concerning a 74 year old female with morphine and penicillin allergies, diabetes, hypertension and hyperlipidaemia who on 23-APR-2008 was vaccinated with ZOSTAVAX (Oka/Merck) (lot # 656858/0356U). Concomitant therapy included ACTOS, NORVASC, glyburide, metoprolol, metformin, simvastatin (MSD) and lisinopril-HCTZ. On 24-APR-2008, approximately 24 hours after vaccination the patient was "flat on her back with muscle aches and back aches. It was like night and day." She went to her physician on 29-APR-2008 and was found to have left sciatica down to her left anterior thigh. She had a "positive straight leg raise". She was treated with MEDROL, cyclobenzaprine hydrochloride (MSD) and TYLENOL with codeine. She also had xrays done. The patient then saw an orthopedist in May 2008 for an evaluation. An MRI of her lumbar spine indicated degenerative disc disease with disc protrusion in L3 and L4. She had diminished range of motion and tenderness of the left hip. Her reflexes are "okay" and there is no spinal stenosis. The orthopedist concluded degenerative disc disease with left bursitis. The patient was injected with a steroid and had xrays done. At some point she had to be in a wheel chair but currently she is using a walker. Left bursitis and degenerative disc were considered to be disabling. No other details. Additional information has been requested.